CVS Health Corporation (CVS) financial statements and ratios from SEC XBRL: revenue $402.07B (TTM), net margin 0.4%, revenue growth 7.8% YoY, P/E 24.4. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $402.07B |
| Net Margin | 0.4% |
| Revenue Growth (YoY) | 7.8% |
| EPS Growth (YoY) | -61.9% |
| FCF Growth (YoY) | 23.4% |
| P/E Ratio | 24.4 |
| EV / EBITDA | 7.1 |
| Price / Book | 1.50 |
| Price / Sales | 0.29 |
| FCF Yield | 17.6% |
| DCF Value (model) | $34.99 |
| DCF Upside vs Price | -62.6% |
| Altman Z-Score | 2.32 (grey) |
| Piotroski F-Score | 7/9 |
| Sector P/E (Consumer Discretionary) | 20.5 |
CVS overview · CVS earnings · CVS KPIs · CVS investor relations · CVS ownership · CVS peers · CVS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.